Drug Profile
Bone marrow cell therapy - DNAmicroarray
Alternative Names: Cardiac stem cell therapy - DNAmicroarray; EBMS; Enhanced bone marrow stem cell therapy; Heart cell therapy - DNAmicroarrayLatest Information Update: 14 Sep 2023
Price :
$50
*
At a glance
- Originator DNAmicroarray
- Class Cell therapies; Heart failure therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 14 Sep 2023 Discontinued - Preclinical for Heart failure in USA (Parenteral)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Heart-failure in USA (Parenteral, Injection)
- 01 Aug 2016 Preclinical trials in Heart failure in USA (Parenteral)